Safety of thalidomide.
作者信息
Crawford C L
出版信息
BMJ. 1994 May 28;308(6941):1437-8. doi: 10.1136/bmj.308.6941.1437b.
Abstract
摘要
相似文献
1
Safety of thalidomide.沙利度胺的安全性。
BMJ. 1994 May 28;308(6941):1437-8. doi: 10.1136/bmj.308.6941.1437b.
2
Safety of thalidomide.沙利度胺的安全性。
BMJ. 1994 Jul 16;309(6948):193-4. doi: 10.1136/bmj.309.6948.193c.
3
Use of thalidomide in leprosy.沙利度胺在麻风病中的应用。
BMJ. 1991 Aug 24;303(6800):470. doi: 10.1136/bmj.303.6800.470-a.
4
Thalidomide peripheral neuropathy.
Trop Doct. 1992 Jul;22(3):139-40.
5
Use of thalidomide in leprosy.
Adverse Drug React Toxicol Rev. 1994 Winter;13(4):177-92.
6
Use of thalidomide in leprosy.沙利度胺在麻风病中的应用。
BMJ. 1991 Oct 26;303(6809):1062-3. doi: 10.1136/bmj.303.6809.1062-c.
7
Thalidomide and leprosy.沙利度胺与麻风病。
Lancet. 1985 Aug 10;2(8450):331. doi: 10.1016/s0140-6736(85)90378-2.
8
Thalidomide in Crohn disease and the risk of peripheral neuropathy.沙利度胺治疗克罗恩病及周围神经病变风险
J Pediatr Gastroenterol Nutr. 2003 Oct;37(4):522. doi: 10.1097/00005176-200310000-00023.
9
Thalidomide neuropathy.沙利度胺神经病变
Lancet. 1969 Apr 5;1(7597):713-4.
10
The troublesome toxicity of peripheral neuropathy with thalidomide.
Leuk Lymphoma. 2006 Nov;47(11):2276-9. doi: 10.1080/10428190600948303.
引用本文的文献
1
Safety of thalidomide.沙利度胺的安全性。
BMJ. 1994 Jul 16;309(6948):193-4. doi: 10.1136/bmj.309.6948.193c.
本文引用的文献
1
US researchers fail to get informed consent.美国研究人员未获得知情同意。
BMJ. 1994 Mar 19;308(6931):739. doi: 10.1136/bmj.308.6931.739a.
2
Thalidomide neuropathy incidence and clinico-electrophysiologic findings in 42 patients.
Arch Dermatol. 1994 Jan;130(1):66-9.
3
Thalidomide revisited.重新审视沙利度胺。
Lancet. 1994 Mar 26;343(8900):795-6. doi: 10.1016/s0140-6736(94)91874-0.
4
Development of polyneuropathy during thalidomide therapy.
Br J Dermatol. 1985 Apr;112(4):475-80. doi: 10.1111/j.1365-2133.1985.tb02323.x.
5
Thalidomide peripheral neuropathy.
Trop Doct. 1992 Jul;22(3):139-40.
Zotero 插件